Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug

Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug

Abstract Camptothecin (CPT) is an anti-cancer drug that effectively treats various cancers, including colon cancer. However, poor solubility and other drawbacks have restricted its chemotherapeutic potential. To overcome these restrictions, CPT was encapsulated in CEF (cyclodextrin-EDTA-FE3O4), a co...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Poorani Krishnan, Mariappan Rajan, Sharmilah Kumari, S. Sakinah, Sivan Padma Priya, Fatin Amira, Lawal Danjuma, Mok Pooi Ling, Sharida Fakurazi, Palanisamy Arulselvan, Akon Higuchi, Ramitha Arumugam, Abdullah A. Alarfaj, Murugan A. Munusamy, Rukman Awang Hamat, Giovanni Benelli, Kadarkarai Murugan, S. Suresh Kumar
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/fd17cfce15764f71a8324eb089ef8a94
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/fd17cfce15764f71a8324eb089ef8a94

Ejemplares similares